Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
Exclusive: Teva faces EU fine for disparaging rival multiple sclerosis medicine, sources say
11:46am, Tuesday, 10'th Sep 2024
Teva , the world's largest generic drugmaker, will be hit with an EU antitrust fine in the coming weeks for disparaging a rival product to its blockbuster multiple sclerosis medicine Copaxone, people
Cheap Teva Stock Should Reward Patient Investors
01:29pm, Monday, 09'th Sep 2024
Teva is poised to benefit from rising demand for generic drugs due to a favorable macro and political environment. The company's valuation is attractive despite its high debt load, which it is likely
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
01:46pm, Friday, 06'th Sep 2024
JP Morgan notes that while there's a resurgence of interest and excitement in new product launches within the specialty group, including branded and complex generics/biosimilars, investors should be d
Medincell's Partner Teva Provides New Update on Pivotal Clinical Phase 3 of Investigational Olanzapine Long-Acting Injectable (LAI)
01:30am, Thursday, 05'th Sep 2024
MONTPELLIER, France--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced during the 22nd Annual Global Healthcare Conference
Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
10:48pm, Wednesday, 04'th Sep 2024
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Morgan Stanley 22nd Annual Global Healthcare Conference Call September 4, 2024 11:30 AM ET Company Participants Richard Francis - Chief Executive Of
2 Reasonably Priced Stocks to Keep an Eye On
03:18pm, Thursday, 29'th Aug 2024
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) and Hewlett Packard Enterprise Co (NYSE:HPE) are this week's picks for Schaeffer's Cheap Seats : Stocks Under $20 segment.
Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
05:00pm, Monday, 26'th Aug 2024
TEL AVIV, Israel, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the Morgan
Teva's Transformation: From Generics Leader To Branded Drug Innovator
03:05pm, Wednesday, 14'th Aug 2024
Step by step, Teva's management is making progress in transforming it from a generic drugmaker into one that will play a key role in the fight against immune-related disorders. Its revenue was about $
The 7 Best Under $20 Stocks to Buy in August 2024
06:00am, Wednesday, 07'th Aug 2024
Cheap stocks are often cheap for a reason. That bit of investing wisdom underscores the need to perform due diligence on a company and not just buy it because the stock trades at a low price.
What Are the Hottest Biotech Stocks Right Now? 3 Top Picks.
02:22pm, Friday, 02'nd Aug 2024
Sometimes the best way to jump into an industry like biotech is to follow the popular trades. Though that may go against the common advice of avoiding hype cycles and the fear of missing out, seeing w
TEVA Q2 Earnings Beat, Generic Business Drives Sales, Stock Up
10:35am, Thursday, 01'st Aug 2024
TEVA reports better-than-expected second-quarter results, beating both earnings and sales estimates. Management raises the 2024 financial outlook.
Teva Pharmaceutical Industries Limited (TEVA) Q2 2024 Earnings Call Transcript
02:02pm, Wednesday, 31'st Jul 2024
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Q2 2024 Earnings Conference Call July 31, 2024 8:00 AM ET Company Participants Richard Francis - President & CEO Eli Kalif - CFO Eric Hughes - Head,
Teva Pharma CEO: Majority of momentum came from innovative business, not GLP-1s
12:14pm, Wednesday, 31'st Jul 2024
Richard Francis, Teva Pharma CEO, joins 'Money Movers' to discuss how much of the company's momentum is around its generic obesity drug, the market's excitement around its GLP-1 drug, and much more.
Teva Pharmaceutical Industries (TEVA) Reports Q2 Earnings: What Key Metrics Have to Say
11:01am, Wednesday, 31'st Jul 2024
Although the revenue and EPS for Teva Pharmaceutical Industries (TEVA) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics com
Is Teva Pharmaceutical Industries (TEVA) Stock Undervalued Right Now?
10:46am, Wednesday, 31'st Jul 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
